GB1556851A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
GB1556851A
GB1556851A GB14173/78A GB1417378A GB1556851A GB 1556851 A GB1556851 A GB 1556851A GB 14173/78 A GB14173/78 A GB 14173/78A GB 1417378 A GB1417378 A GB 1417378A GB 1556851 A GB1556851 A GB 1556851A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB14173/78A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of GB1556851A publication Critical patent/GB1556851A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB14173/78A 1977-04-12 1978-04-11 Pharmaceutical compositions Expired GB1556851A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7710906A FR2387035A1 (fr) 1977-04-12 1977-04-12 Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux

Publications (1)

Publication Number Publication Date
GB1556851A true GB1556851A (en) 1979-11-28

Family

ID=9189287

Family Applications (1)

Application Number Title Priority Date Filing Date
GB14173/78A Expired GB1556851A (en) 1977-04-12 1978-04-11 Pharmaceutical compositions

Country Status (10)

Country Link
JP (1) JPS53130440A (fr)
BE (1) BE865891A (fr)
DE (1) DE2815878C2 (fr)
FR (1) FR2387035A1 (fr)
GB (1) GB1556851A (fr)
GR (1) GR72116B (fr)
IL (1) IL54462A0 (fr)
IT (1) IT1102581B (fr)
NL (1) NL7803895A (fr)
PT (1) PT67885B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385656B (de) * 1982-02-01 1988-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4511557A (en) * 1981-08-24 1985-04-16 Gauri Kailash Kumar Pharmaceutical composition
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT385656B (de) * 1982-02-01 1988-05-10 Sandoz Ag Verfahren zur herstellung einer pharmazeutischen zusammensetzung zur nasalen verabreichung, enthaltend ein cyclisches ergotpeptidalkaloid

Also Published As

Publication number Publication date
GR72116B (fr) 1983-09-15
IT7848852A0 (it) 1978-04-11
FR2387035B1 (fr) 1980-03-21
JPS627167B2 (fr) 1987-02-16
IT1102581B (it) 1985-10-07
DE2815878C2 (de) 1986-10-09
FR2387035A1 (fr) 1978-11-10
NL7803895A (nl) 1978-10-16
BE865891A (fr) 1978-10-11
JPS53130440A (en) 1978-11-14
IL54462A0 (en) 1978-07-31
PT67885A (fr) 1978-05-01
DE2815878A1 (de) 1978-10-19
PT67885B (fr) 1980-04-07

Similar Documents

Publication Publication Date Title
ZA781398B (en) Pharmaceutical compositions
HK73785A (en) Pharmaceutical compositions
GB2003028B (en) Pharmaceutical compositions
JPS53109934A (en) Pharmaceutical composition
JPS5484022A (en) Pharmaceutical composition
JPS53133637A (en) Pharmaceutical composition
JPS5449333A (en) Pharmaceutical composition
PH15193A (en) Pharmaceutical composition
GB2008403B (en) Pharmaceutical compositions
GB2002229B (en) Pharmaceutical composition
GB2021409B (en) Pharmaceutical composition
ZA78671B (en) Pharmaceutical compositions
ZA784470B (en) Pharmaceutical compositions including antithormbotic compositions
JPS5394038A (en) Pharmaceutical composition
JPS5486607A (en) Solid pharmaceutical composition
NZ186334A (en) Oxadiazolopyrimidines:pharmaceutical compositions
IL54220A (en) Pharmaceutical compositions comprising trans-broparestrol
ZA78387B (en) Pharmaceutical compositions
GB2008408B (en) Pharmaceutical compositions
ZA7812B (en) Pharmaceutical compositions
NZ188040A (en) 1-phenylethanolamine derivatives pharmaceutical compositions
GB1556851A (en) Pharmaceutical compositions
ZA782736B (en) Pharmaceutical compositions
JPS545045A (en) Pharmaceutical composition
JPS542338A (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee